SEARCH

SEARCH BY CITATION

References

  • 1
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36: 729740, 1993
  • 2
    OMERACT Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Maastricht, The Netherlands April 29–May 3, 1992. J Rheumatol 20: 527591, 1993
  • 3
    Mallya RK, Mace BEW: The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheumatol Rehab 20: 1417, 1981
  • 4
    Van Riel PLCM, Reekers P, van de Putte LBA, Gribnau FWJ: Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis. Tissue Antigens 22: 194199, 1983
  • 5
    Van der Heijde DMFM, van 't Hof MA, van Riel PLCM, Theunisse LM, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LBA: Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49: 916920, 1990
  • 6
    Davis MJ, Dawes PT, Fowler PD, Sheeran TP, Shadforth MF, Ziade F, Collins M, Jones P: Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis. Br J Rheumatol 29: 111115, 1990
  • 7
    Van der Heijde DMFM, van 't Hof MA, van Riel PLCM, van Leeuwen MA, van Rijswijk MH, van de Putte LBA: A comparison of validity of single variables and composed indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 51: 177181, 1992
  • 8
    Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393406, 1968
  • 9
    Prevoo MLL, van Riel PLCM, van 't Hof MA, van Rijswijk MH, van Leeuwen MA, Kuper HH, van de Putte LBA: Validity and reliability of joint indices: a longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol 32: 589594, 1993
  • 10
    Fuchs HA, Pincus T: Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 37: 470475, 1994
  • 11
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315324, 1988
  • 12
    Fuchs HA, Brooks RH, Callahan LF, Pincus T: A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 32: 531537, 1989
  • 13
    Van der Heijde DMFM, van Riel PLCM, van der Putte LBA: Sensitivity of the Dutch health assessment questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine. Scand J Rheumatol 19: 407412, 1990
  • 14
    Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, Decker JL, Genant HK, Gofton JP, Goodman N, Larsen A, Lidsky MD, Pussila P, Weinstein AS, Weissman BN: How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 28: 13261335, 1985
  • 15
    Tugwell P, Bombardier C: A methodological framework for developing and selecting endpoints in clinical trials. J Rheumatol 9: 758762, 1982
  • 16
    Fuchs HA: The use of the disease activity score in the analysis of clinical trials in rheumatoid arthritis. J Rheumatol 20: 18631866, 1993